ON DEMAND: Biomarkers for inflammatory bowel diseases: Needs & opportunities for microbiome-targeted drug development
Date & Time
Friday, June 5, 2020, 9:00 AM - 5:00 PM
Gerard Honig

• Why biomarkers are critical to address unmet patient needs and accelerate drug development in the IBD field.

• Examples of microbiome-based biomarkers for risk stratification in IBD.

• Scientific, regulatory and commercial criteria for biomarker selection in IBD drug development.

Session Type
Virtual Session Link